The main cells of interest in our analytic platform are CTCs, which are obtained by negative selection and sorting via flow cytometry. You can find further information here [link to site].

In addition to pioneering personalized genetic testing for cancer, RGCC is deeply engaged in pharmaceutical research and development, operating from our cutting-edge facilities in Europe. Our esteemed scientists regularly publish peer-reviewed research, earning respect on a global scale. 

No, the blood-brain barrier prevents tumor cells from entering the bloodstream. Consequently, we cannot obtain or isolate any tumor cells from a blood sample. However, in such cases, cerebrospinal fluid can be used.

Certainly, patients with lymphoma or leukemia can utilize an RGCC test to measure the number of circulating tumor cells (CTC) they have.

The most comprehensive test is the "Onconomics Plus" test. This provides information on the sensitivity or resistance of the patient's tumour cells to certain cancer drugs and shows options for targeted therapy or an alternative treatment method with organic substances. The test also contains information about the development of the tumour and its potential by identifying epigenetic tumour markers relevant for the therapy, which are crucial for the correct therapeutic approach.

RGCC has developed a range of tests to discover, analyse and screen cancer cells. We currently offer 11 tests that can detect potential early signs of cancer, monitor existing diagnosed cancers and provide personalised guidance on the most effective combination of cancer treatments and therapies, including complementary therapies.

If you have any symptoms of cancer, you should speak to a qualified medical professional urgently. You can book a consultation with an RGCC network clinician by filling out this form. 

RGCC tests are exclusively accessible to the RGCC network of healthcare professionals. Healthcare professionals interested in joining the RGCC network can contact us by filling out this form. Patients interested in ordering an RGCC test can request one through their healthcare provider. To locate the nearest RGCC-registered clinician to you, contact us. 

RGCC tests are tailored to offer medical insights and guidance for clinicians. The results contain information that requires interpretation by the clinician overseeing your care. If you are a patient seeking more information about RGCC's test offerings, you can locate your nearest RGCC clinician by contacting us via this form.

RGCC tests are exclusively accessible to healthcare professionals within the RGCC network. We're open to connecting with individuals and organizations that align with our values. If you're a health professional seeking information about joining the RGCC network, please reach out to us via this contact form. 

Upon placing an order for your RGCC test, the next step is to send the patient’s blood sample. Our detailed shipping instructions ensure the sample's safe and secure arrival at our cutting-edge laboratory facility in Greece. After processing, we deliver a comprehensive breakdown of the test results. We encourage you and your patient to review the findings together and collaborate on crafting a personalized treatment plan based on our insights. For more information on the RGCC test process, visit our dedicated test pages or download our informative patient information leaflet. 

Our methods are accredited by the International Organisation for Standardisation (ISO). Details of our certifications can be found on our website.